<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib103">
 <label>103</label>
 <mixed-citation publication-type="other" id="sref103">US Food and Drug Administration. Recommendations for Investigational COVID-19 Convalescent Plasma. 
  <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma" id="interref0030" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma</ext-link>. Published August 23, 2020. Accessed April 15, 2020.
 </mixed-citation>
</ref>
